Published in Ann Rheum Dis on June 22, 2006
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis (AMiRA) | NCT03619876
Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 4.15
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum (2009) 2.33
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis (2007) 2.22
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol (2011) 2.20
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther (2008) 2.15
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis (2011) 2.01
Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ (2012) 1.94
Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med (2008) 1.77
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis (2010) 1.76
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum (2008) 1.73
Integrated safety in tocilizumab clinical trials. Arthritis Res Ther (2011) 1.55
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients. Ann Rheum Dis (2012) 1.54
A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol Int (2011) 1.45
IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol (2012) 1.44
Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34
Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis (2008) 1.28
Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis (2009) 1.27
Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci (2014) 1.26
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis (2010) 1.21
Toward high-throughput phenotyping: unbiased automated feature extraction and selection from knowledge sources. J Am Med Inform Assoc (2015) 1.19
Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum (2013) 1.18
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS One (2009) 1.09
Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am (2010) 1.06
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum (2008) 1.04
Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol (2015) 1.02
The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol (2010) 1.01
Cardiovascular risk. Br J Clin Pharmacol (2012) 0.97
Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis. Mediators Inflamm (2013) 0.95
Cardiovascular safety of biologic therapies for the treatment of RA. Nat Rev Rheumatol (2011) 0.92
Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population. Arthritis Res Ther (2010) 0.91
To Tell or Not to Tell: Shared Decision Making, CAM Use and Disclosure Among Underserved Patients with Rheumatic Diseases. Integr Med Insights (2012) 0.90
The role of TL1A and DR3 in autoimmune and inflammatory diseases. Mediators Inflamm (2013) 0.88
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis (2015) 0.87
Rheumatoid arthritis and cardiovascular disease: an update on treatment issues. Curr Opin Rheumatol (2013) 0.87
Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study. Sci Rep (2014) 0.87
Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. J Am Heart Assoc (2014) 0.87
Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention. Semin Arthritis Rheum (2010) 0.86
Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health (Larchmt) (2009) 0.85
Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol (2013) 0.84
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis. Biologics (2013) 0.82
A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis. Medicine (Baltimore) (2015) 0.80
A Statistical Approach for Testing Cross-Phenotype Effects of Rare Variants. Am J Hum Genet (2016) 0.80
Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum (2012) 0.80
Co-Occurrence of Arthritis and Stroke amongst Middle-Aged and Older Adults in Canada. Stroke Res Treat (2014) 0.79
Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts. Immunology (2014) 0.79
Cardiovascular risk factor management in patients with RA compared to matched non-RA patients. Rheumatology (Oxford) (2015) 0.79
Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Biomed Res Int (2015) 0.79
Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study. Arthritis Care Res (Hoboken) (2013) 0.79
Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice. Biochem Biophys Res Commun (2009) 0.79
Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol (2016) 0.78
Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study. J Rheumatol (2014) 0.78
Prolong Exposure of NSAID in Patients With RA Will Decrease the Risk of Dementia: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) (2016) 0.77
Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. Arthritis Res Ther (2014) 0.77
A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects. J Pharm Bioallied Sci (2015) 0.77
Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis. PLoS One (2016) 0.76
Co-morbidity index in rheumatoid arthritis: time to think. Clin Rheumatol (2015) 0.76
The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases? F1000 Med Rep (2009) 0.76
Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry. Clin Rheumatol (2015) 0.76
Managing the drug treatment of rheumatoid arthritis. Aust Prescr (2017) 0.75
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open (2016) 0.75
Rheumatoid arthritis: TNF inhibitors and cardiovascular risk management in RA. Nat Rev Rheumatol (2016) 0.75
Differential Amino Acid, Carbohydrate and Lipid Metabolism Perpetuations Involved in a Subtype of Rheumatoid Arthritis with Chinese Medicine Cold Pattern. Int J Mol Sci (2016) 0.75
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis (2015) 0.75
Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis. Pharmacol Res Perspect (2016) 0.75
Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis. J Korean Med Sci (2015) 0.75
Risk for cardiovascular disease in Japanese patients with rheumatoid arthritis: a large-scale epidemiological study using a healthcare database. Springerplus (2016) 0.75
The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease. BMC Cardiovasc Disord (2016) 0.75
Is rheumatoid arthritis a risk factor for cardiovascular disease? Nat Clin Pract Rheumatol (2007) 0.75
Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. Semin Thromb Hemost (2014) 0.75
The Risk for Cardiovascular Events Associated with Hyperlipdemia among Patients with and Without Rheumatoid Arthritis. J Arthritis (2015) 0.75
Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa! F1000 Med Rep (2010) 0.75
Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication. BMC Musculoskelet Disord (2011) 0.75
Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study. Dermatol Ther (Heidelb) (2016) 0.75
IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis. Sci Rep (2017) 0.75
Rituximab for Rheumatoid Arthritis. Rheumatol Ther (2015) 0.75
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. BMJ Open (2016) 0.75
Cytokine Imbalance as a Common Mechanism in Both Psoriasis and Rheumatoid Arthritis. Mediators Inflamm (2017) 0.75
Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting. BMC Musculoskelet Disord (2015) 0.75
The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors. Sci Rep (2016) 0.75
Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA. Rheumatol Int (2016) 0.75
The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis. Clin Rheumatol (2014) 0.75
Biventricular thrombus and associated myocardial infarction in a rheumatoid arthritis patient: a case report and literature review. Clin Rheumatol (2013) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care (2005) 7.73
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31
The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am (2001) 3.58
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med (2004) 2.39
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum (2004) 2.32
Quality of care for patients with rheumatoid arthritis. JAMA (2000) 2.30
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum (2003) 2.29
A strengthening programme for weak associations. Int J Epidemiol (1988) 2.19
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis (2005) 2.11
Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol (1999) 1.93
Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis (2004) 1.75
Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum (2004) 1.69
Increased mortality in rheumatoid arthritis. Scand J Rheumatol (1982) 1.67
Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol (2002) 1.56
Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol (2004) 1.42
Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation (2004) 1.40
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol (2000) 1.24
Value of an Endpoints Committee versus the use of nosologists for validating cause of death. Contemp Clin Trials (2006) 1.23
Serum cholesterol and risk of rheumatoid arthritis in a cohort of 52 800 men and women. Br J Rheumatol (1996) 1.02
Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA (1990) 10.01
Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med (1983) 8.56
A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am (1993) 7.53
Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med (1982) 7.14
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol (2001) 7.04
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
Rheumatoid arthritis. Lancet (2001) 6.14
Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med (1991) 5.94
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med (1987) 4.57
Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q (1989) 4.49
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46
Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care (1999) 4.35
Incidence and preventability of adverse drug events in nursing homes. Am J Med (2000) 4.33
The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA (1992) 4.28
The North American spine society lumbar spine outcome assessment Instrument: reliability and validity tests. Spine (Phila Pa 1976) (1996) 3.94
Physician motivations for nonscientific drug prescribing. Soc Sci Med (1989) 3.84
A connective tissue disease screening questionnaire for population studies. Ann Epidemiol (1995) 3.72
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ (2012) 3.44
Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med (1985) 3.37
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
Evaluating drugs after their approval for clinical use. N Engl J Med (1993) 3.19
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum (1994) 3.15
Risk factors for adverse drug events among nursing home residents. Arch Intern Med (2001) 3.12
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA (2000) 3.03
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
The rational clinical examination. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. JAMA (2001) 2.62
Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med (2000) 2.62
Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med (1994) 2.62
Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health (1998) 2.53
Validity and responsiveness of the Knee Society Clinical Rating System in comparison with the SF-36 and WOMAC. J Bone Joint Surg Am (2001) 2.53
Paradoxical relations of drug treatment with mortality in older persons. Epidemiology (2001) 2.52
The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally. Eye (Lond) (2007) 2.35
Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health (1996) 2.33
Refilling and switching of antiepileptic drugs and seizure-related events. Clin Pharmacol Ther (2010) 2.31
Gender differences in patient preferences may underlie differential utilization of elective surgery. Am J Med (1997) 2.31
A controlled trial of educational outreach to improve blood transfusion practice. JAMA (1993) 2.28
Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med (1993) 2.27
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension (2001) 2.24
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens (1997) 2.21
Measurement properties of a self-administered outcome measure in lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.16
Acute megakaryocytic leukemia (M7) in children. Mayo Clin Proc (1989) 2.13
Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med (2001) 2.13
Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. N Engl J Med (1984) 2.12
Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc (1997) 2.09
Methotrexate for chronic diseases in adults. N Engl J Med (1995) 2.07
Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Ann Intern Med (1997) 2.06
Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med (1997) 2.01
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther (2009) 1.98
Aging and the anticoagulant response to warfarin therapy. Ann Intern Med (1992) 1.97
Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum (1997) 1.92
Treatment for glaucoma: adherence by the elderly. Am J Public Health (1993) 1.90
The ambiguous relation between aging and adverse drug reactions. Ann Intern Med (1991) 1.82
Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc (1999) 1.82
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry (2001) 1.80
Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care (1996) 1.77
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol (2001) 1.77
How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med (1997) 1.75
Development and preliminary psychometric testing of a new OA pain measure--an OARSI/OMERACT initiative. Osteoarthritis Cartilage (2008) 1.75
Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol (1995) 1.74
Measurement error correction for logistic regression models with an "alloyed gold standard". Am J Epidemiol (1997) 1.72
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J (1999) 1.70
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis (2007) 1.70
Zolpidem use and hip fractures in older people. J Am Geriatr Soc (2001) 1.68
Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis. Spine (Phila Pa 1976) (2000) 1.68
Carpal tunnel release. Correlations with preoperative symptomatology. Clin Orthop Relat Res (1996) 1.67
Economic and policy analysis of university-based drug "detailing". Med Care (1986) 1.67
In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum (1991) 1.66
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol (2001) 1.64
Improving drug use in elderly patients: getting to the next level. JAMA (2001) 1.63
Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol (1989) 1.61
Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment. JAMA (1990) 1.61
Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (1995) 1.60
The prognostic importance of patient pre-operative expectations of surgery for lumbar spinal stenosis. Patient Educ Couns (1998) 1.60
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther (2015) 1.59
Synovial tissue response to treatment with Campath-1H. Arthritis Rheum (1995) 1.59
Causation of bias: the episcope. Epidemiology (2001) 1.57
Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol (1996) 1.57
Classification criteria revisited. Arthritis Rheum (1991) 1.53
Can history and physical examination be used as markers of quality? An analysis of the initial visit note in musculoskeletal care. Med Care (2000) 1.52
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood (1998) 1.52
Psychoactive medication use in intermediate-care facility residents. JAMA (1988) 1.50
Predictors of uncontrolled hypertension in ambulatory patients. Hypertension (2001) 1.49
Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Osteoarthritis Cartilage (2008) 1.49
Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis (2007) 1.49
Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients. J Exp Med (1993) 1.47
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia (2005) 1.46
Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis (2001) 1.45
Blood donation by the elderly. Clinical and policy considerations. JAMA (1987) 1.45
Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology (2004) 1.44
Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol (1996) 1.44
Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf (1997) 1.44
The total hip arthroplasty outcome evaluation form of the American Academy of Orthopaedic Surgeons. Results of a nominal group process. The American Academy of Orthopaedic Surgeons Task Force on Outcome Studies. J Bone Joint Surg Am (1991) 1.44
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
Total hip arthroplasty: use and select complications in the US Medicare population. Am J Public Health (1996) 1.43
Treatment of rheumatoid arthritis. Arthritis Care Res (1989) 1.42